Gene clues could steer chemo for hard-to-treat breast cancer
Disease control
Recruiting now
This study tests whether a gene test can help doctors pick the right chemotherapy for people with a certain type of advanced breast cancer (HR+ metastatic). About 64 adults whose cancer has stopped responding to hormone therapy will receive a chemo drug called capecitabine. The g…
Phase: PHASE2 • Sponsor: Sonya Reid • Aim: Disease control
Last updated May 01, 2026 15:59 UTC